210 8980180
info@fairlifelcc.com
Fairlife Logo
  • ABOUT US
  • REAL STORIES
  • NEWS
  • I WANT TO CONTRIBUTE
  • CONTACT
  • DONATION
  • COLUMN-1
    • ABOUT US
      • Our story
      • Partnerships
      • Supporters
      • Scientific Associates
      • Specialist Partners
  • COLUMN-2
    • REAL STORIES
      • Read all the stories
    • I WANT TO CONTRIBUTE
      • Make a donation
      • Become a volunteer
      • Become a friend
      • Become a sponsor
  • COLUMN-3
    • NEWS
      • Press Releases
      • Articles
      • Publicity – Interviews
    • OUR ACTIONS
      • Conferences
      • Webinars
      • FairLife Activations
  • Greek
  • LUNG CANCER
  • PREVENTION
  • DIAGNOSIS
  • TREATMENTS
  • MANAGEMENT
  • SUPPORT
  • Lung Cancer
  • COLUMN-1
    • What is it
    • Types of Lung Cancer
  • COLUMN-2
    • Symptoms
  • COLUMN-3
    • Covid 19
  • COLUMN-4
  • Prevention
  • COLUMN-1
    • Risk factors
    • Know the symptoms
    • Learn about early diagnosis
  • COLUMN-2
    • Early Screening
      • Are you eligible for screening?
      • Smoking cessation
  • COLUMN-3
  • COLUMN-4
  • Diagnosis
  • COLUMN-1
    • Diagnosing Lung Cancer
      • Imaging Studies
      • Laboratory Examinations
      • Tissue Biopsies
  • COLUMN-2
    • Biomarker Testing
      • What is a biomarker
      • What is biomarker testing
      • Types of biomarkers
      • How are biomarkers tested
      • What’s included in a biomarker testing report
      • Questions to discuss regarding biomarker testing
  • COLUMN-3
    • Diagnosis and Staging
      • Types of Lung Cancer
      • Stages of Lung Cancer
      • Multidisciplinary Tumor Board
  • COLUMN-4
  • Treatments
  • COLUMN-1
    • Surgical Intervention
    • Radiation Therapy
  • COLUMN-2
    • Chemotherapy
    • Immunotherapy
  • COLUMN-3
    • Targeted Therapy
  • COLUMN-4
  • Management
  • COLUMN-1
    • Treatment Side-effect Management
  • COLUMN-2
    • Complementary therapies
    • Living with lung cancer
  • COLUMN-3
  • COLUMN-4
  • Support
  • COLUMN-1
    • Oncology Centers
    • Smoking Cessation Clinics
  • COLUMN-2
    • Patients’ Rights
    • Physiotherapy
  • COLUMN-3
    • Dietary Support
  • COLUMN-4
Fairlife Logo
  • Greek
  • Make a donation
  • Prevention
    • Risk Factors
    • Early Detection
    • Early Screening
      • Risk factors
      • Know the symptoms
      • Learn about early diagnosis
      • Smoking cessation
  • Diagnosis
    • Diagnosing Lung Cancer
    • Imaging Studies
    • Laboratory Examinations
    • Tissue Biopsies
    • Biomarker Testing
      • What is a biomarker
      • What is biomarker testing
      • Types of biomarkers
      • How are biomarkers tested
      • What’s included in a biomarker testing report
      • Questions to discuss regarding biomarker testing
    • Diagnosis and Staging
      • Types of Lung Cancer
      • Non-Small Cell Lung Cancer
      • Stages of Lung Cancer
      • Multidisciplinary Tumor Board
  • Treatments
    • Surgical Intervention
    • Radiation Therapy
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Management
    • Treatment Side-effect Management
    • Complementary therapies
    • Living with lung cancer
  • Support
    • Oncology Centers
    • Patients’ Rights
    • Dietary Support
    • Physiotherapy
  • Lung Cancer
    • What is it
    • Types of Lung Cancer
    • Symptoms
    • Covid 19
  • About us
    • Who we are
    • Our story
    • Partnerships
    • Specialist Partners
    • Scientific Associates
  • Real Stories
  • Contribute
    • Make a donation
    • Become a volunteer
    • Become a friend
  • News
    • Articles
    • Press Releases
    • Publicity – Interviews
  • Our actions
    • FairLife Activations
    • Conferences
    • Webinars
    • Participation in events
  • Contact
213 016 5784
info@fairlifecc.com

FairLife L.C.C. was awarded by the Hellenic Thoracic Society at the 31st Panhellenic Pulmonology Conference

  • December 13 2022
  • News, Press Releases

FairLife L.C.C. was awarded by the Hellenic Thoracic Society

For its substantial contribution to public awareness, regarding prevention and early diagnosis of lung cancer

 

On Sunday, December 10, at the 31st Panhellenic Pulmonology Conference, FairLife L.C.C. was awarded by the Hellenic Thoracic Society for its valuable and substantial contribution to public awareness, regarding prevention and early diagnosis of lung cancer.

The award was presented to Mrs. Korina Pateli-Bell, President of FairLife L.C.C. by Mr. Eleutherios Zervas, General Secretary of the Hellenic Thoracic Society and Mr. Stelios Loukidis, President of the Hellenic Thoracic Society commented: “It is important for the Hellenic Thoracic Society to support initiatives such as Fairlife’s, which emphasize the need for the implementation of lung cancer screening in our country. Initially, as a pilot program in the Public Health System, in coordinated framework, through interdisciplinary cooperation, and ensuring a continuity for participants. We warmly welcome and support such actions and will continue to collaborate with Fairlife to achieve these essential objectives.” 

At the award ceremony, Korina Pateli-Bell, President of FairLife L.C.C., stated: “I would like to thank the HTS for the invitation and for the honorary award to FairLife. Each award is a moral reward for our organization, but the present one is special indeed, coming from within the scientific community and in fact from experts, specialized in  lung health.  FairLife’s earliest videos focused on screening awareness, which is, after all, one of our main objectives. But truth is, we cannot achieve much without cooperation. We need to walk in the same direction with scientists, the State, patients and all the stakeholders, while acknowledging the main role of the pulmonologist in the fight against lung cancer, but also the needs of patients, who are, after all, the final beneficiaries of this enormous effort. At FairLife, we are optimistic that we will soon be able to see many advances in this direction.”

 




Fairlife LCC’s main actions to inform and promote early screening

In its 2 years of operation, FairLife L.C.C implements actions directed by patients’ needs, from diagnosis to treatment.  Actions are also implemented to inform and raise public awareness, regarding lung cancer prevention.

From the very beginning, FairLife L.C.C.’s main concern has been to inform and promote screening, so it can be included in the National Health System.  In particular, the following actions have been implemented:

  • Informative videos and audiovisual material on early screening, through the digital informative library Learn Act Hope, with the participation of pulmonologists.
  • “Lung Health” Screening Program.Provided free of charge to people belonging to vulnerable social groups. FairLife is partnering with HHG Group and Metropolitan Hospital on this activity. The “Lung Health” Screening Program was presented in September 2022, in Chicago, at the IASLC North America Conference on Lung Cancer (NACLC 2022).
  • Awareness campaigns Get Checked (2021)and Get Diagnosed (2022) for early diagnosis and screening, through collaboration between FairLife LCC and the European Lung Cancer Organization LuCE.
  • In November 2021, Lung Cancer Awareness Month, FairLife LCC in collaboration with the Institute of Health Policy, conducted the first study on early screening in Greece.Based on a predictive, stochastic model, screening leads to a significant reduction in deaths by 24.61% and a reduction in years of life lost by 30.9%.
  • Project “Luca”:Lung cancer awareness and screening campaign, featuring Luca, a fictional hero, diagnosed with lung cancer.
  • Webinar on early diagnosiswith the attendance of excellent health scientists, discussing lung cancer prevention strategies, screening and the importance of early diagnosis.
  • New “14 minutes of life”informational broadcasts series with topics related to Lung Cancer Prevention and Early Screening.

Signing of the Social Initiative Charter, a social initiative, a  “Breath of Life”, by the Hellenic Thoracic Society, in which parties involved commit to contribute to a culture of lung cancer prevention by encouraging screening and smoking cessation.

FairLife L.C.C.:
Napoleontos 18, 16675 Glyfada                                  

Tel: 213 0165784
FairLine 111 57

Email:  info@fairlifelcc.com
Facebook: https://www.facebook.com/fairlifelcc
Website: https://fairlifelcc.com/
Instagram:https://www.instagram.com/fairlifelcc/
YouTube: https://www.youtube.com/channel/UCxv4C1yQoBQOITPKjk6JY3AYouTube
LinkedIn: https://www.linkedin.com/company/fair-life-lung-cancer-care/?viewAsMember=true
Twitter : https://twitter.com/fairlifelcc 

Περισσότερα άρθρα

5th Annual Conference “Lung Cancer – From Prevention to Holistic Care: Bridging Science and Society – Centering on Life”

31 October 2025

KORINA PATELI-BELL “No patient and no family without support”

27 October 2025

Αthens – 5th Event on “Healthy Lungs” Initiative of FairLife L.C.C.

2 October 2025

Any information provided on diseases is intended for the purpose of providing general information to the public and under no circumstances can it substitute the advice of a doctor or other competent health professional.

Subscribe to our newsletter

    • ABOUT US
    • SYMPTOMS
    • TREATMENT
    • STOP SMOKING
    • ONCOLOGY CENTERS
    • PSYCHOSOCIAL SUPPORT
    • CLINICAL TRAILS
    • I WANT TO CONTRIBUTE
    • TERMS & CONDITIONS
    • COOKIES POLICY
    • PRIVACY POLICY
    6 Evelpidon Ave - 16672, Greece - 210 8980180 - info@fairlifelcc.com
    6 Evelpidon Ave - 16672, Greece
    210 8980180
    info@fairlifelcc.com
    FairLife L.C.C. © 2025
    With thanks to the following companies for the website creation
    • Ελληνικά (Greek)
    • English
    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.